Recently published study reveals effective and safe treatment alternative carried out by world renowned experts.
Chronic lower extremity ulcers (CLEU) are very common, have various causes and are difficult to heal. The objective of the prospective study was to analyse the response of CLEU to an Er:YAG 2940 nm laser equipped with unique RecoSMA® technology. Leading experts in the field of laser medicine have now published their evidence in a respected international journal
Evaluation of results achieved was carried out in 18 patients who signed up for the study. The gender distribution was as follows: 16 women and 2 men with an average age of 66. Patients were enrolled in the study by questionnaires, histologies and clinical visual correlation of progress by photographs taken before each session (16 sessions in total), which were then analysed with the help of computer software.
Results after 16 treatment sessions showed complete healing of ulcers or a decrease of their initial area by at least 50% in more than 50% of patients treated. The Student’s t-test and Fisher's exact test were used for the statistical analysis.
LINLINE’s RecoSMA ® technology is unique and used to treat a variety of tissue conditions. It is based on a sophisticated laser optical system, converting the main laser beam into 10,000 microbeams per square cm, which simultaneously interact with the tissue. The powerful mechanical waves from every micro beam scatter from the surface to the deeper layers creating non-thermal partial damage of human cells up to 6 mm in depth. This new technology is unlike any other currently available - the tissue treated undergoes total regeneration, functional restoration, and the promotion of fast neovascularisation. The evidence of the effectiveness of the new RecoSMA® technology is backed up by numerous pre-clinical and clinical studies for aged skin rejuvenation and lifting, correction of scars, treating trophic ulcers and many other applications.